Sunday, June 10, 2018 9:35:44 AM
I don't like the looks of it. $7700 resistance failed to break, and now we are testing the low end of support at $7100-$7200. If support does not hold, it is back to $6000's, which will have ramifications for PLUS1's dollar value as well.
One way of looking at it I suppose is that cheapies may be on the way. But you know how that usually turns out on the OTC
I still can't decide if we are going back to $20K or back to $0...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
